Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 1
2001 1
2005 1
2008 1
2009 1
2011 2
2012 6
2013 4
2014 2
2015 7
2016 7
2017 4
2018 3
2019 8
2020 8
2021 13
2022 5
2023 10
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial.
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E; PIONEER 8 Investigators. Zinman B, et al. Diabetes Care. 2019 Dec;42(12):2262-2271. doi: 10.2337/dc19-0898. Epub 2019 Sep 17. Diabetes Care. 2019. PMID: 31530667 Free PMC article. Clinical Trial.
Environmental factors affecting female fertility.
Sakali AK, Bargiota A, Bjekic-Macut J, Macut D, Mastorakos G, Papagianni M. Sakali AK, et al. Among authors: bargiota a. Endocrine. 2024 Oct;86(1):58-69. doi: 10.1007/s12020-024-03940-y. Epub 2024 Jul 2. Endocrine. 2024. PMID: 38954374 Review.
Diabetes Mellitus and Heart Failure.
Triposkiadis F, Xanthopoulos A, Bargiota A, Kitai T, Katsiki N, Farmakis D, Skoularigis J, Starling RC, Iliodromitis E. Triposkiadis F, et al. Among authors: bargiota a. J Clin Med. 2021 Aug 19;10(16):3682. doi: 10.3390/jcm10163682. J Clin Med. 2021. PMID: 34441977 Free PMC article. Review.
Chronic Stress in Pregnancy Is Associated with Low Birth Weight: A Meta-Analysis.
Matsas A, Panopoulou P, Antoniou N, Bargiota A, Gryparis A, Vrachnis N, Mastorakos G, Kalantaridou SN, Panoskaltsis T, Vlahos NF, Valsamakis G. Matsas A, et al. Among authors: bargiota a. J Clin Med. 2023 Dec 14;12(24):7686. doi: 10.3390/jcm12247686. J Clin Med. 2023. PMID: 38137756 Free PMC article. Review.
Environmental factors affecting pregnancy outcomes.
Sakali AK, Papagianni M, Bargiota A, Rasic-Markovic A, Macut D, Mastorakos G. Sakali AK, et al. Among authors: bargiota a. Endocrine. 2023 Jun;80(3):459-469. doi: 10.1007/s12020-023-03307-9. Epub 2023 Feb 2. Endocrine. 2023. PMID: 36729371 Review.
80 results